Showing 31-34 of 34 Results
Breast Cancer: CCTG MA39
TAILOR RT: A Randomized trial of regional radiotherapy in biomarker low risk node positive and T3N0 breast cancer.
Breast Cancer: EA1181
(CompassHER2-pCR)-Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response Part 1 Component of: The CompassHER2 Trials.
Breast Cancer: A091901
Optimizing Endocrine Therapy Through Motivational Interviewing And Text Interventions.
Bladder Cancer: VOLGA- D910PC00001-Phase III
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer.
Showing 31-34 of 34 Results